Cure My Disease

Don't miss your cure!

 Log in / Sign up

Overdose prevention program aims to save homeless Veterans' lives

NCT ID NCT07716202

Not yet recruiting Disease control Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests a program that provides overdose education and naloxone (a drug that reverses opioid overdoses) to homeless veterans at risk. The program is being rolled out at VA sites that serve veterans in supportive housing. Researchers will measure how well sites adopt the program and whether it reaches those in need.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
overdose education and naloxone distribution (OEND) program
What this could lead to
If successful, this program could significantly reduce opioid overdose deaths among homeless veterans by making education and naloxone widely available.
What could go wrong
The trial focuses on implementation, not direct health outcomes, so it may show that sites can adopt the program without actually reducing overdoses. Results depend on real-world use and follow-through.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOMELESSNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

substance-related disorder acute opioid poisoning prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HOMELESSNESS OPIOID EDUCATION AND NALOXONE DISTRIBUTION (OEND) SUBSTANCE USE DISORDER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • VA Palo Alto Health Care System, Palo Alto, CA

    Palo Alto, California, 94304-1207, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.